Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae
Previously partnered on a diabetes program, the two companies now will collaborate on a BACE inhibitor will potential as a disease-altering therapy in Alzheimer’s.
Previously partnered on a diabetes program, the two companies now will collaborate on a BACE inhibitor will potential as a disease-altering therapy in Alzheimer’s.